Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by kristian7on Dec 12, 2016 2:17am

251 Views

Post# 25584042

RE:RE:RE:RE:RE:RE:RE:RE:Early Christmas?

Great post Viper !

viper1957 wrote: Man, it has become a full time job putting these D Bag shorters and disgruntled ex-TST shareholders on ignore! Likely more will show up later today to ramp up their scare tactics in preparation for Monday's market open. These guys are pathetic.

I hope the legitimate newbies on this board are aware of what they are up to. Just take a look at PLI's chart from the beginning of the year. We went through this same BS in January and the upward reversal will be the same this time (possibly better). A deal is in the works and the BLA for PG will be filed soon. DO NOT sell the shorters your shares! You will be sorry if you do.

Note to D bag shorters - don't bother replying to me because you are likely on ignore and, if you aren't, you will be.

GLTA!

Viper